These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9028363)
1. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363 [TBL] [Abstract][Full Text] [Related]
2. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy]. Li L; Yao D; Chen X Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429 [TBL] [Abstract][Full Text] [Related]
3. Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Cheng X; Okada M; Oishi T; Terakawa N Cancer; 1998 Feb; 82(4):697-702. PubMed ID: 9477102 [TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma. Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385 [TBL] [Abstract][Full Text] [Related]
6. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione. Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092 [TBL] [Abstract][Full Text] [Related]
7. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck? Vural E; Alexiou M; Hunt J; Korourian S; Hanna E Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322 [TBL] [Abstract][Full Text] [Related]
8. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer]. Huang J; Gu M; Chen C Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):458-61. PubMed ID: 9639737 [TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma. Chen CL; Sheen TS; Lou IU; Huang AC Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264 [TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959 [TBL] [Abstract][Full Text] [Related]
13. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy. Unsal M; Akpolat I; Kandemir B Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J; Tan PH; Thiyagarajan J; Bay BH Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061 [TBL] [Abstract][Full Text] [Related]
15. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789 [TBL] [Abstract][Full Text] [Related]
16. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol. Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493 [TBL] [Abstract][Full Text] [Related]
17. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer. Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391 [TBL] [Abstract][Full Text] [Related]
18. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer. Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426 [TBL] [Abstract][Full Text] [Related]
19. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age. Hoensch H; Peters WH; Roelofs HM; Kirch W Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540 [TBL] [Abstract][Full Text] [Related]
20. [Glutathione-S-transferase expression in oral squamous cell carcinoma]. Pannone G; Lo Muzio L; Pappalardo S; Bambini F; Rubini C; Fioroni M; Fanali S Minerva Stomatol; 2000 Mar; 49(3):107-17. PubMed ID: 20047209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]